{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:26:10Z","timestamp":1791930370618,"version":"4.3.4"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>We summarise the physiological changes and risk factors for hypertension in females, potential sex-specific management approaches, and long-term prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Findings<\/jats:title>\n                    <jats:p>Pregnancy and menopause are two key phases of the life cycle where females undergo significant biological and physical changes, making them more prone to developing hypertension. Gestational hypertension occurs from changes in maternal cardiac output, kidney function, metabolism, or placental vasculature, with one in ten experiencing pregnancy complications such as intrauterine growth restriction and delivery complications such as premature birth. Post-menopausal hypertension occurs as the protective effects of oestrogen are reduced and the sympathetic nervous system becomes over-activated with ageing. Increasing evidence suggests that post-menopausal females with high blood pressure (BP) experience greater risk of cardiovascular events at lower BP thresholds, and greater vulnerability to treatment-related adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Hypertension is a key risk factor for cardiovascular disease in females. Current BP treatment guidelines and recommendations are similar for both sexes, without addressing sex-specific factors. Future investigations into ideal diagnostic thresholds, BP control targets and treatment regimens in females are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11897-024-00672-y","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T04:01:56Z","timestamp":1718078516000},"page":"322-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Pathophysiology, Prognosis and Treatment of Hypertension in Females from Pregnancy to Post-menopause: A Review"],"prefix":"10.1007","volume":"21","author":[{"given":"Simeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta E","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4145-6461","authenticated-orcid":false,"given":"Sonali R","family":"Gnanenthiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"672_CR1","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Jr. Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines. Circulation. 2017;138(17):e484\u2013594.","DOI":"10.1161\/CIR.0000000000000596"},{"issue":"5","key":"672_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1161\/01.HYP.37.5.1199","volume":"37","author":"JF Reckelhoff","year":"2001","unstructured":"Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37(5):1199\u2013208.","journal-title":"Hypertension"},{"issue":"2","key":"672_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/hr.2011.190","volume":"35","author":"E Pimenta","year":"2012","unstructured":"Pimenta E. Hypertension in women. Hypertens Res. 2012;35(2):148\u201352.","journal-title":"Hypertens Res"},{"issue":"7","key":"672_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/jhh.2010.77","volume":"25","author":"JS de Munter","year":"2011","unstructured":"de Munter JS, Agyemang C, van Valkengoed IG, Bhopal R, Stronks K. Sex difference in blood pressure among south Asian diaspora in Europe and North America and the role of BMI: a meta-analysis. J Hum Hypertens. 2011;25(7):407\u201317.","journal-title":"J Hum Hypertens"},{"issue":"7","key":"672_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/CIRCULATIONAHA.120.049360","volume":"143","author":"H Ji","year":"2021","unstructured":"Ji H, Niiranen TJ, Rader F, Henglin M, Kim A, Ebinger JE, et al. Sex differences in blood pressure associations with Cardiovascular outcomes. Circulation. 2021;143(7):761\u20133.","journal-title":"Circulation"},{"issue":"3","key":"672_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11883-018-0716-z","volume":"20","author":"P Di Giosia","year":"2018","unstructured":"Di Giosia P, Giorgini P, Stamerra CA, Petrarca M, Ferri C, Sahebkar A. Gender Differences in Epidemiology, Pathophysiology, and treatment of hypertension. Curr Atheroscler Rep. 2018;20(3):13.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"672_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/HYPERTENSIONAHA.117.09537","volume":"70","author":"W Shen","year":"2017","unstructured":"Shen W, Zhang T, Li S, Zhang H, Xi B, Shen H, et al. Race and sex differences of long-term blood pressure profiles from childhood and adult hypertension: the Bogalusa Heart Study. Hypertension. 2017;70(1):66\u201374.","journal-title":"Hypertension"},{"key":"672_CR8","unstructured":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017., et al. Lancet (London England). 2018;392(10159):1923\u201394."},{"key":"672_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2018.09.030","volume":"278","author":"LM O\u2019Keeffe","year":"2018","unstructured":"O\u2019Keeffe LM, Simpkin AJ, Tilling K, Anderson EL, Hughes AD, Lawlor DA, et al. Sex-specific trajectories of measures of cardiovascular health during childhood and adolescence: a prospective cohort study. Atherosclerosis. 2018;278:190\u20136.","journal-title":"Atherosclerosis"},{"issue":"3","key":"672_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s11906-012-0260-0","volume":"14","author":"R Lima","year":"2012","unstructured":"Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep. 2012;14(3):254\u201360.","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"672_CR11","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/HYPERTENSIONAHA.117.09246","volume":"70","author":"J Tooher","year":"2017","unstructured":"Tooher J, Thornton C, Makris A, Ogle R, Korda A, Hennessy A. All Hypertensive disorders of pregnancy increase the risk of Future Cardiovascular Disease. Hypertension. 2017;70(4):798\u2013803.","journal-title":"Hypertension"},{"issue":"1","key":"672_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","volume":"21","author":"W Wang","year":"2021","unstructured":"Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study. BMC Pregnancy Childbirth. 2021;21(1):364.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9","key":"672_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11906-020-01070-0","volume":"22","author":"A Agrawal","year":"2020","unstructured":"Agrawal A, Wenger NK. Hypertension during pregnancy. Curr Hypertens Rep. 2020;22(9):64.","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"672_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1161\/HYPERTENSIONAHA.107.105742","volume":"51","author":"M Coylewright","year":"2008","unstructured":"Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: an age-old debate. Hypertension. 2008;51(4):952\u20139.","journal-title":"Hypertension"},{"key":"672_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12905-015-0219-9","volume":"15","author":"MK Son","year":"2015","unstructured":"Son MK, Lim NK, Lim JY, Cho J, Chang Y, Ryu S, et al. Difference in blood pressure between early and late menopausal transition was significant in healthy Korean women. BMC Womens Health. 2015;15:64.","journal-title":"BMC Womens Health"},{"issue":"6","key":"672_CR16","first-page":"427","volume":"3","author":"J Staessen","year":"1989","unstructured":"Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens. 1989;3(6):427\u201333.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"672_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and Management recommendations for International Practice. Hypertension. 2018;72(1):24\u201343.","journal-title":"Hypertension"},{"key":"672_CR18","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A et al. 2023 ESH guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023."},{"issue":"4","key":"672_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10928-020-09677-1","volume":"47","author":"JM Kazma","year":"2020","unstructured":"Kazma JM, van den Anker J, Allegaert K, Dallmann A, Ahmadzia HK. Anatomical and physiological alterations of pregnancy. J Pharmacokinet Pharmacodyn. 2020;47(4):271\u201385.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"4","key":"672_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s004040000104","volume":"264","author":"A Elsheikh","year":"2001","unstructured":"Elsheikh A, Creatsas G, Mastorakos G, Milingos S, Loutradis D, Michalas S. The renin-aldosterone system during normal and hypertensive pregnancy. Arch Gynecol Obstet. 2001;264(4):182\u20135.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"672_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1172\/JCI102905","volume":"33","author":"MJ Gray","year":"1954","unstructured":"Gray MJ, Plentl AA. The variations of the sodium space and the total exchangeable sodium during pregnancy. J Clin Invest. 1954;33(3):347\u201353.","journal-title":"J Clin Invest"},{"key":"672_CR22","doi-asserted-by":"publisher","first-page":"5320156","DOI":"10.1155\/2019\/5320156","volume":"2019","author":"U Kampmann","year":"2019","unstructured":"Kampmann U, Knorr S, Fuglsang J, Ovesen P. Determinants of maternal insulin resistance during pregnancy: an updated overview. J Diabetes Res. 2019;2019:5320156.","journal-title":"J Diabetes Res"},{"issue":"12","key":"672_CR23","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1097\/00004872-200412000-00019","volume":"22","author":"G Grassi","year":"2004","unstructured":"Grassi G, Dell\u2019Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22(12):2363\u20139.","journal-title":"J Hypertens"},{"issue":"1","key":"672_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1152\/japplphysiol.00463.2004","volume":"98","author":"CK Roberts","year":"2005","unstructured":"Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND. A high-fat, refined-carbohydrate diet induces endothelial dysfunction and oxidant\/antioxidant imbalance and depresses NOS protein expression. J Appl Physiol (1985). 2005;98(1):203\u201310.","journal-title":"J Appl Physiol (1985)"},{"issue":"6","key":"672_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1357-2725(02)00311-4","volume":"35","author":"S Engeli","year":"2003","unstructured":"Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol. 2003;35(6):807\u201325.","journal-title":"Int J Biochem Cell Biol"},{"issue":"11 Suppl 1","key":"672_CR26","first-page":"S3","volume":"19","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. [2018 ESC\/ESH guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. G Ital Cardiol (Rome). 2018;19(11 Suppl 1):S3\u201373.","journal-title":"G Ital Cardiol (Rome)"},{"key":"672_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2020.09.001","volume":"82","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P, Reboldi G, Angeli F. The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations. Eur J Intern Med. 2020;82:1\u20136.","journal-title":"Eur J Intern Med"},{"key":"672_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12916-014-0163-9","volume":"12","author":"JM Dodd","year":"2014","unstructured":"Dodd JM, McPhee AJ, Turnbull D, Yelland LN, Deussen AR, Grivell RM, et al. The effects of antenatal dietary and lifestyle advice for women who are overweight or obese on neonatal health outcomes: the LIMIT randomised trial. BMC Med. 2014;12:163.","journal-title":"BMC Med"},{"key":"672_CR29","doi-asserted-by":"publisher","first-page":"g1285","DOI":"10.1136\/bmj.g1285","volume":"348","author":"JM Dodd","year":"2014","unstructured":"Dodd JM, Turnbull D, McPhee AJ, Deussen AR, Grivell RM, Yelland LN, et al. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ. 2014;348:g1285.","journal-title":"BMJ"},{"issue":"10203","key":"672_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(19)31282-6","volume":"394","author":"T Easterling","year":"2019","unstructured":"Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet. 2019;394(10203):1011\u201321.","journal-title":"Lancet"},{"key":"672_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/eurheartj\/4.suppl_G.35","volume":"4","author":"H Lardoux","year":"1983","unstructured":"Lardoux H, Gerard J, Blazquez G, Chouty F, Flouvat B. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol. Eur Heart J. 1983;4:35\u201340. Suppl G.","journal-title":"Eur Heart J"},{"issue":"2","key":"672_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/pds.2068","volume":"20","author":"RL Davis","year":"2011","unstructured":"Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, Smith D, et al. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf. 2011;20(2):138\u201345.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"672_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/10641955.2020.1791902","volume":"39","author":"M Rezk","year":"2020","unstructured":"Rezk M, Emarh M, Masood A, Dawood R, El-Shamy E, Gamal A, et al. Methyldopa versus Labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial. Hypertens Pregnancy. 2020;39(4):393\u20138.","journal-title":"Hypertens Pregnancy"},{"issue":"6","key":"672_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1471-0528.1977.tb12616.x","volume":"84","author":"CW Redman","year":"1977","unstructured":"Redman CW, Beilin LJ, Bonnar J. Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects. Br J Obstet Gynaecol. 1977;84(6):419\u201326.","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"672_CR35","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1471-0528.1995.tb10874.x","volume":"102","author":"H Nisell","year":"1995","unstructured":"Nisell H, Lintu H, Lunell NO, Mollerstrom G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol. 1995;102(11):876\u201381.","journal-title":"Br J Obstet Gynaecol"},{"key":"672_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.preghy.2019.05.009","volume":"17","author":"M Salama","year":"2019","unstructured":"Salama M, Rezk M, Gaber W, Hamza H, Marawan H, Gamal A, et al. Methyldopa versus Nifedipine or no medication for treatment of chronic hypertension during pregnancy: a multicenter randomized clinical trial. Pregnancy Hypertens. 2019;17:54\u20138.","journal-title":"Pregnancy Hypertens"},{"key":"672_CR37","first-page":"CD002252","volume":"10","author":"E Abalos","year":"2018","unstructured":"Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10:CD002252.","journal-title":"Cochrane Database Syst Rev"},{"key":"672_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajp.2018.10.024","volume":"38","author":"AS Nayak","year":"2018","unstructured":"Nayak AS, Nachane HB. Risk analysis of suicidal ideations and postpartum depression with antenatal alpha methyldopa use. Asian J Psychiatr. 2018;38:42\u20134.","journal-title":"Asian J Psychiatr"},{"issue":"5","key":"672_CR39","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1161\/HYPERTENSIONAHA.117.09972","volume":"70","author":"LM Webster","year":"2017","unstructured":"Webster LM, Myers JE, Nelson-Piercy C, Harding K, Cruickshank JK, Watt-Coote I, et al. Labetalol Versus Nifedipine as Antihypertensive Treatment for chronic hypertension in pregnancy: a Randomized Controlled Trial. Hypertension. 2017;70(5):915\u201322.","journal-title":"Hypertension"},{"issue":"6","key":"672_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1055\/s-2007-994629","volume":"10","author":"JL Kurtzman","year":"1993","unstructured":"Kurtzman JL, Thorp JM Jr., Spielman FJ, Mueller RC, Cefalo RC. Do nifedipine and verapamil potentiate the cardiac toxicity of magnesium sulfate? Am J Perinatol. 1993;10(6):450\u20132.","journal-title":"Am J Perinatol"},{"issue":"2","key":"672_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0002-9378(88)80072-3","volume":"159","author":"GD Waisman","year":"1988","unstructured":"Waisman GD, Mayorga LM, Camera MI, Vignolo CA, Martinotti A. Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia? Am J Obstet Gynecol. 1988;159(2):308\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"672_CR42","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/0002-9378(90)90867-7","volume":"162","author":"K Ales","year":"1990","unstructured":"Ales K. Magnesium plus nifedipine. Am J Obstet Gynecol. 1990;162(1):288.","journal-title":"Am J Obstet Gynecol"},{"issue":"34","key":"672_CR43","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","volume":"39","author":"V Regitz-Zagrosek","year":"2018","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165\u2013241.","journal-title":"Eur Heart J"},{"issue":"12","key":"672_CR44","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrcardio.2015.172","volume":"12","author":"PG Pieper","year":"2015","unstructured":"Pieper PG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol. 2015;12(12):718\u201329.","journal-title":"Nat Rev Cardiol"},{"issue":"7421","key":"672_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","volume":"327","author":"LA Magee","year":"2003","unstructured":"Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955\u201360.","journal-title":"BMJ"},{"issue":"8","key":"672_CR46","first-page":"e5507","volume":"11","author":"S Un Nisa","year":"2019","unstructured":"Un Nisa S, Shaikh AA, Kumar R. Maternal and fetal outcomes of pregnancy-related Hypertensive disorders in a Tertiary Care Hospital in Sukkur, Pakistan. Cureus. 2019;11(8):e5507.","journal-title":"Cureus"},{"issue":"2","key":"672_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0929-6646(08)60126-6","volume":"107","author":"CM Liu","year":"2008","unstructured":"Liu CM, Cheng PJ, Chang SD. Maternal complications and perinatal outcomes associated with gestational hypertension and severe preeclampsia in Taiwanese women. J Formos Med Assoc. 2008;107(2):129\u201338.","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"672_CR48","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","volume":"51","author":"LC Chappell","year":"2008","unstructured":"Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51(4):1002\u20139.","journal-title":"Hypertension"},{"issue":"7217","key":"672_CR49","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0140-6736(61)91196-5","volume":"2","author":"EM Adams","year":"1961","unstructured":"Adams EM, Macgillivray I. Long-term effect of preeclampsia on blood-pressure. Lancet. 1961;2(7217):1373\u20135.","journal-title":"Lancet"},{"issue":"5","key":"672_CR50","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/0002-9378(86)90336-4","volume":"155","author":"BM Sibai","year":"1986","unstructured":"Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986;155(5):1011\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"672_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/hrt.77.2.154","volume":"77","author":"P Hannaford","year":"1997","unstructured":"Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart. 1997;77(2):154\u20138.","journal-title":"Heart"},{"issue":"2","key":"672_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1081\/PRG-100100136","volume":"19","author":"R Marin","year":"2000","unstructured":"Marin R, Gorostidi M, Portal CG, Sanchez M, Sanchez E, Alvarez J. Long-term prognosis of hypertension in pregnancy. Hypertens Pregnancy. 2000;19(2):199\u2013209.","journal-title":"Hypertens Pregnancy"},{"key":"672_CR53","doi-asserted-by":"crossref","unstructured":"Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C et al. Preeclampsia and Future Cardiovascular Health: a systematic review and Meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2).","DOI":"10.1161\/CIRCOUTCOMES.116.003497"},{"issue":"4","key":"672_CR54","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/HJH.0b013e328335c29a","volume":"28","author":"VD Garovic","year":"2010","unstructured":"Garovic VD, Bailey KR, Boerwinkle E, Hunt SC, Weder AB, Curb D, et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens. 2010;28(4):826\u201333.","journal-title":"J Hypertens"},{"issue":"17","key":"672_CR55","doi-asserted-by":"publisher","first-page":"e009382","DOI":"10.1161\/JAHA.118.009382","volume":"7","author":"W Ying","year":"2018","unstructured":"Ying W, Catov JM, Ouyang P. Hypertensive disorders of pregnancy and future maternal Cardiovascular risk. J Am Heart Assoc. 2018;7(17):e009382.","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"672_CR56","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1136\/heartjnl-2015-308098","volume":"101","author":"DC Scantlebury","year":"2015","unstructured":"Scantlebury DC, Kane GC, Wiste HJ, Bailey KR, Turner ST, Arnett DK, et al. Left ventricular hypertrophy after hypertensive pregnancy disorders. Heart. 2015;101(19):1584\u201390.","journal-title":"Heart"},{"issue":"3","key":"672_CR57","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/HYPERTENSIONAHA.110.152975","volume":"56","author":"LL Yanes","year":"2010","unstructured":"Yanes LL, Romero DG, Iliescu R, Zhang H, Davis D, Reckelhoff JF. Postmenopausal hypertension: role of the renin-angiotensin system. Hypertension. 2010;56(3):359\u201363.","journal-title":"Hypertension"},{"key":"672_CR58","doi-asserted-by":"publisher","first-page":"798958","DOI":"10.3389\/fmed.2021.798958","volume":"8","author":"G Gallo","year":"2021","unstructured":"Gallo G, Volpe M, Savoia C. Endothelial dysfunction in hypertension: current concepts and clinical implications. Front Med (Lausanne). 2021;8:798958.","journal-title":"Front Med (Lausanne)"},{"issue":"968","key":"672_CR59","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/pgmj.2005.036053","volume":"82","author":"B Jani","year":"2006","unstructured":"Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J. 2006;82(968):357\u201362.","journal-title":"Postgrad Med J"},{"issue":"9","key":"672_CR60","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/CS20100476","volume":"120","author":"DR Seals","year":"2011","unstructured":"Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond). 2011;120(9):357\u201375.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"672_CR61","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/hr.2012.138","volume":"35","author":"Y Higashi","year":"2012","unstructured":"Higashi Y, Kihara Y, Noma K. Endothelial dysfunction and hypertension in aging. Hypertens Res. 2012;35(11):1039\u201347.","journal-title":"Hypertens Res"},{"issue":"1","key":"672_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/157488712799363253","volume":"7","author":"OM Reslan","year":"2012","unstructured":"Reslan OM, Khalil RA. Vascular effects of estrogenic menopausal hormone therapy. Rev Recent Clin Trials. 2012;7(1):47\u201370.","journal-title":"Rev Recent Clin Trials"},{"issue":"2","key":"672_CR63","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1161\/01.CIR.94.2.122","volume":"94","author":"HV Huikuri","year":"1996","unstructured":"Huikuri HV, Pikkujamsa SM, Airaksinen KE, Ikaheimo MJ, Rantala AO, Kauma H, et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation. 1996;94(2):122\u20135.","journal-title":"Circulation"},{"issue":"11","key":"672_CR64","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1161\/01.CIR.94.11.2850","volume":"94","author":"H Tsuji","year":"1996","unstructured":"Tsuji H, Larson MG, Venditti FJ Jr., Manders ES, Evans JC, Feldman CL, et al. Impact of reduced heart rate variability on risk for cardiac events. Framingham Heart Study Circulation. 1996;94(11):2850\u20135.","journal-title":"Framingham Heart Study Circulation"},{"issue":"9","key":"672_CR65","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1440-1681.2007.04663.x","volume":"34","author":"TM Saleh","year":"2007","unstructured":"Saleh TM, Connell BJ. Role of oestrogen in the central regulation of autonomic function. Clin Exp Pharmacol Physiol. 2007;34(9):827\u201332.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"672_CR66","first-page":"103","volume":"8","author":"K Yalamudi","year":"2017","unstructured":"Yalamudi K. Study of comparison between autonomic dysfunction and Dyslipidemia in healthy postmenopausal women. J Midlife Health. 2017;8(3):103\u20139.","journal-title":"J Midlife Health"},{"issue":"5","key":"672_CR67","first-page":"S387","volume":"4","author":"GD James","year":"1986","unstructured":"James GD, Sealey JE, Muller F, Alderman M, Madhavan S, Laragh JH. Renin relationship to sex, race and age in a normotensive population. J Hypertens Suppl. 1986;4(5):S387\u20139.","journal-title":"J Hypertens Suppl"},{"issue":"1","key":"672_CR68","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/01.CIR.95.1.39","volume":"95","author":"H Schunkert","year":"1997","unstructured":"Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation. 1997;95(1):39\u201345.","journal-title":"Circulation"},{"issue":"6","key":"672_CR69","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1210\/jc.2003-030242","volume":"88","author":"MC Carr","year":"2003","unstructured":"Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88(6):2404\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"672_CR70","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/HJH.0b013e32830bfdd9","volume":"26","author":"E Casiglia","year":"2008","unstructured":"Casiglia E, Tikhonoff V, Caffi S, Bascelli A, Schiavon L, Guidotti F, et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens. 2008;26(10):1983\u201392.","journal-title":"J Hypertens"},{"issue":"10","key":"672_CR71","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/HJH.0b013e32830b895c","volume":"26","author":"R Cifkova","year":"2008","unstructured":"Cifkova R, Pitha J, Lejskova M, Lanska V, Zecova S. Blood pressure around the menopause: a population study. J Hypertens. 2008;26(10):1976\u201382.","journal-title":"J Hypertens"},{"issue":"21","key":"672_CR72","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1093\/eurheartj\/ehn427","volume":"29","author":"F Turnbull","year":"2008","unstructured":"Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J. 2008;29(21):2669\u201380.","journal-title":"Eur Heart J"},{"issue":"4","key":"672_CR73","doi-asserted-by":"publisher","first-page":"100553","DOI":"10.1016\/j.xcrm.2022.100553","volume":"3","author":"BE Bierer","year":"2022","unstructured":"Bierer BE, Meloney LG, Ahmed HR, White SA. Advancing the inclusion of underrepresented women in clinical research. Cell Rep Med. 2022;3(4):100553.","journal-title":"Cell Rep Med"},{"issue":"5","key":"672_CR74","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/sj.jhh.1000815","volume":"13","author":"B Koch","year":"1999","unstructured":"Koch B, Oparil S, Stimpel M. Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women. J Hum Hypertens. 1999;13(5):337\u201342.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"672_CR75","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000006799","volume":"89","author":"M Stimpel","year":"1998","unstructured":"Stimpel M, Koch B, Oparil S. Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide). Cardiology. 1998;89(4):271\u20136.","journal-title":"Cardiology"},{"key":"672_CR76","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1046\/j.1523-1755.62.s82.8.x","volume":"82","author":"F Fernandez-Vega","year":"2002","unstructured":"Fernandez-Vega F, Abellan J, Vegazo O, De Vinuesa SG, Rodriguez JC, Maceira B, et al. Angiotensin II type 1 receptor blockade to control blood pressure in postmenopausal women: influence of hormone replacement therapy. Kidney Int Suppl. 2002;82:S36\u201341.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"672_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0378-5122(98)00037-1","volume":"30","author":"M Stimpel","year":"1998","unstructured":"Stimpel M, Koch B, Weber MA. Comparison between moexipril and atenolol in obese postmenopausal women with hypertension. Maturitas. 1998;30(1):69\u201377.","journal-title":"Maturitas"},{"issue":"12","key":"672_CR78","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1291\/hypres.29.1007","volume":"29","author":"H Ikeda","year":"2006","unstructured":"Ikeda H, Inoue T, Uemura S, Kaibara R, Tanaka H, Node K. Effects of Candesartan for middle-aged and elderly women with hypertension and menopausal-like symptoms. Hypertens Res. 2006;29(12):1007\u201312.","journal-title":"Hypertens Res"},{"issue":"5","key":"672_CR79","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/01.HYP.36.5.780","volume":"36","author":"S Wassertheil-Smoller","year":"2000","unstructured":"Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson J, Wong N, et al. Hypertension and its treatment in postmenopausal women: baseline data from the women\u2019s Health Initiative. Hypertension. 2000;36(5):780\u20139.","journal-title":"Hypertension"},{"issue":"1","key":"672_CR80","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1365-2362.2003.01103.x","volume":"33","author":"L Rejnmark","year":"2003","unstructured":"Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L. Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded latin-square multiple cross-over study in postmenopausal osteopenic women. Eur J Clin Invest. 2003;33(1):41\u201350.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"672_CR81","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/13697137.2013.842226","volume":"17","author":"SM Kujala","year":"2014","unstructured":"Kujala SM, Poyhonen-Alho M, Kaaja RJ. Effects of sympatholytic therapy on postmenopausal symptoms in hypertensive postmenopausal women. Climacteric. 2014;17(4):356\u201362.","journal-title":"Climacteric"},{"issue":"1","key":"672_CR82","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amjhyper.2003.08.016","volume":"17","author":"R Fogari","year":"2004","unstructured":"Fogari R, Preti P, Zoppi A, Corradi L, Pasotti C, Rinaldi A, et al. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens. 2004;17(1):77\u201381.","journal-title":"Am J Hypertens"},{"issue":"3","key":"672_CR83","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s002280050616","volume":"55","author":"E Agabiti-Rosei","year":"1999","unstructured":"Agabiti-Rosei E, Ambrosioni E, Pirelli A, Stimpel M, Zanchetti A. Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension. MADAM study group. Moexipril as Antihypertensive Drug after Menopause. Eur J Clin Pharmacol. 1999;55(3):185\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"672_CR84","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/jch.12004","volume":"14","author":"D Hayoz","year":"2012","unstructured":"Hayoz D, Zappe DH, Meyer MA, Baek I, Kandra A, Joly MP, et al. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen. J Clin Hypertens (Greenwich). 2012;14(11):773\u20138.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"8","key":"672_CR85","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6","volume":"80","author":"AL Fitzpatrick","year":"1997","unstructured":"Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer. 1997;80(8):1438\u201347.","journal-title":"Cancer"},{"key":"672_CR86","doi-asserted-by":"crossref","unstructured":"Appiah D, Schreiner PJ, Demerath EW, Loehr LR, Chang PP, Folsom AR. Association of Age at Menopause With Incident Heart failure: a prospective cohort study and Meta-analysis. J Am Heart Assoc. 2016;5(8).","DOI":"10.1161\/JAHA.116.003769"},{"issue":"9","key":"672_CR87","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jacc.2017.06.053","volume":"70","author":"J Saw","year":"2017","unstructured":"Saw J, Humphries K, Aymong E, Sedlak T, Prakash R, Starovoytov A, et al. Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence. J Am Coll Cardiol. 2017;70(9):1148\u201358.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"672_CR88","first-page":"134","volume":"60","author":"H Sumino","year":"2003","unstructured":"Sumino H, Ichikawa S, Itoh H, Utsugi T, Ohyama Y, Umeda M, et al. Hormone replacement therapy decreases insulin resistance and lipid metabolism in Japanese postmenopausal women with impaired and normal glucose tolerance. Horm Res. 2003;60(3):134\u201342.","journal-title":"Horm Res"},{"issue":"7","key":"672_CR89","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/sj.jhh.1001431","volume":"16","author":"K Kawecka-Jaszcz","year":"2002","unstructured":"Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens. 2002;16(7):509\u201316.","journal-title":"J Hum Hypertens"},{"issue":"6","key":"672_CR90","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/S0002-9378(96)70201-6","volume":"174","author":"GD Giraud","year":"1996","unstructured":"Giraud GD, Morton MJ, Wilson RA, Burry KA, Speroff L. Effects of estrogen and progestin on aortic size and compliance in postmenopausal women. Am J Obstet Gynecol. 1996;174(6):1708\u201317. discussion 17\u2009\u2013\u20098.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"672_CR91","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0008-6363(98)00219-3","volume":"41","author":"Y Nagai","year":"1999","unstructured":"Nagai Y, Earley CJ, Kemper MK, Bacal CS, Metter EJ. Influence of age and postmenopausal estrogen replacement therapy on carotid arterial stiffness in women. Cardiovasc Res. 1999;41(1):307\u201311.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"672_CR92","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/GME.0000000000001067","volume":"25","author":"Y Swica","year":"2018","unstructured":"Swica Y, Warren MP, Manson JE, Aragaki AK, Bassuk SS, Shimbo D, et al. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the women\u2019s Health Initiative hormone therapy trials. Menopause. 2018;25(7):753\u201361.","journal-title":"Menopause"},{"issue":"4","key":"672_CR93","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7326\/0003-4819-135-4-200108210-00007","volume":"135","author":"A Scuteri","year":"2001","unstructured":"Scuteri A, Bos AJ, Brant LJ, Talbot L, Lakatta EG, Fleg JL. Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Ann Intern Med. 2001;135(4):229\u201338.","journal-title":"Ann Intern Med"},{"issue":"2","key":"672_CR94","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00042192-200203000-00008","volume":"9","author":"M Christ","year":"2002","unstructured":"Christ M, Seyffart K, Tillmann HC, Wehling M. Hormone replacement in postmenopausal women: impact of progestogens on autonomic tone and blood pressure regulation. Menopause. 2002;9(2):127\u201336.","journal-title":"Menopause"},{"issue":"1","key":"672_CR95","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40885-021-00175-1","volume":"27","author":"BK Yoon","year":"2021","unstructured":"Yoon BK, Sung J, Song YM, Kim SM, Son KA, Yoo JH, et al. Effects of menopausal hormone therapy on ambulatory blood pressure and arterial stiffness in postmenopausal Korean women with grade 1 hypertension: a randomized, placebo-controlled trial. Clin Hypertens. 2021;27(1):18.","journal-title":"Clin Hypertens"},{"issue":"13","key":"672_CR96","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","volume":"112","author":"WB White","year":"2005","unstructured":"White WB, Pitt B, Preston RA, Hanes V. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension. Circulation. 2005;112(13):1979\u201384.","journal-title":"Circulation"},{"issue":"3 Pt 1","key":"672_CR97","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/01.gme.0000243572.63322.f7","volume":"14","author":"RA Preston","year":"2007","unstructured":"Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause. 2007;14(3 Pt 1):408\u201314.","journal-title":"Menopause"},{"issue":"9","key":"672_CR98","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/09513590.2016.1183629","volume":"32","author":"X Zhao","year":"2016","unstructured":"Zhao X, Zhang XF, Zhao Y, Lin X, Li NY, Paudel G, et al. Effect of combined drospirenone with estradiol for hypertensive postmenopausal women: a systemic review and meta-analysis. Gynecol Endocrinol. 2016;32(9):685\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"672_CR99","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2018.12.021","volume":"141","author":"M Tadic","year":"2019","unstructured":"Tadic M, Cuspidi C, Grassi G, Ivanovic B. Gender-specific therapeutic approach in arterial hypertension - challenges ahead. Pharmacol Res. 2019;141:181\u20138.","journal-title":"Pharmacol Res"},{"issue":"16","key":"672_CR100","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.jacc.2018.02.033","volume":"71","author":"NK Wenger","year":"2018","unstructured":"Wenger NK, Arnold A, Bairey Merz CN, Cooper-DeHoff RM, Ferdinand KC, Fleg JL, et al. Hypertension across a woman\u2019s life cycle. J Am Coll Cardiol. 2018;71(16):1797\u2013813.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"672_CR101","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/ajh\/7.11.1012","volume":"7","author":"I Os","year":"1994","unstructured":"Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens. 1994;7(11):1012\u20135.","journal-title":"Am J Hypertens"},{"issue":"2","key":"672_CR102","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1378\/chest.103.2.601","volume":"103","author":"M Sonnenblick","year":"1993","unstructured":"Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest. 1993;103(2):601\u20136.","journal-title":"Chest"},{"issue":"12","key":"672_CR103","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/qjmed\/hcg157","volume":"96","author":"KM Chow","year":"2003","unstructured":"Chow KM, Szeto CC, Wong TY, Leung CB, Li PK. Risk factors for thiazide-induced hyponatraemia. QJM. 2003;96(12):911\u20137.","journal-title":"QJM"},{"issue":"4","key":"672_CR104","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1159\/000013496","volume":"19","author":"A Spital","year":"1999","unstructured":"Spital A. Diuretic-induced hyponatremia. Am J Nephrol. 1999;19(4):447\u201352.","journal-title":"Am J Nephrol"},{"issue":"4","key":"672_CR105","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.107.105296","volume":"51","author":"I Os","year":"2008","unstructured":"Os I, Franco V, Kjeldsen SE, Manhem K, Devereux RB, Gerdts E, et al. Effects of Losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008;51(4):1103\u20138.","journal-title":"Hypertension"},{"issue":"10","key":"672_CR106","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1210\/jcem.84.10.6124","volume":"84","author":"P August","year":"1999","unstructured":"August P. Hypertension in men. J Clin Endocrinol Metab. 1999;84(10):3451\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"672_CR107","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0002-9149(97)89205-3","volume":"77","author":"RA Kloner","year":"1996","unstructured":"Kloner RA, Sowers JR, DiBona GF, Gaffney M, Wein M. Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol. 1996;77(9):713\u201322.","journal-title":"Am J Cardiol"},{"issue":"6","key":"672_CR108","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/HJH.0000000000002398","volume":"38","author":"AJ Lawson","year":"2020","unstructured":"Lawson AJ, Hameed MA, Brown R, Cappuccio FP, George S, Hinton T, et al. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals. J Hypertens. 2020;38(6):1165\u201373.","journal-title":"J Hypertens"},{"key":"672_CR109","doi-asserted-by":"publisher","first-page":"k4247","DOI":"10.1136\/bmj.k4247","volume":"363","author":"ERC Millett","year":"2018","unstructured":"Millett ERC, Peters SAE, Woodward M. Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants. BMJ. 2018;363:k4247.","journal-title":"BMJ"},{"issue":"18","key":"672_CR110","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1212\/WNL.0000000000004602","volume":"89","author":"P Gilsanz","year":"2017","unstructured":"Gilsanz P, Mayeda ER, Glymour MM, Quesenberry CP, Mungas DM, DeCarli C, et al. Female sex, early-onset hypertension, and risk of dementia. Neurology. 2017;89(18):1886\u201393.","journal-title":"Neurology"},{"issue":"1","key":"672_CR111","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1038\/s41598-021-86397-7","volume":"11","author":"KJ Anstey","year":"2021","unstructured":"Anstey KJ, Peters R, Mortby ME, Kiely KM, Eramudugolla R, Cherbuin N, et al. Association of sex differences in dementia risk factors with sex differences in memory decline in a population-based cohort spanning 20\u201376 years. Sci Rep. 2021;11(1):7710.","journal-title":"Sci Rep"},{"issue":"1","key":"672_CR112","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/eurjpc\/zwab068","volume":"29","author":"E Kringeland","year":"2022","unstructured":"Kringeland E, Tell GS, Midtbo H, Igland J, Haugsgjerd TR, Gerdts E. Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study. Eur J Prev Cardiol. 2022;29(1):147\u201354.","journal-title":"Eur J Prev Cardiol"},{"issue":"9438","key":"672_CR113","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet"},{"key":"672_CR114","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2017.04.009","volume":"261","author":"G Albrektsen","year":"2017","unstructured":"Albrektsen G, Heuch I, Lochen ML, Thelle DS, Wilsgaard T, Njolstad I, et al. Risk of incident myocardial infarction by gender: interactions with serum lipids, blood pressure and smoking. The Tromso Study 1979\u20132012. Atherosclerosis. 2017;261:52\u20139.","journal-title":"Atherosclerosis"},{"issue":"2","key":"672_CR115","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/HYPERTENSIONAHA.122.19693","volume":"80","author":"DS Picone","year":"2023","unstructured":"Picone DS, Stoneman E, Cremer A, Schultz MG, Otahal P, Hughes AD, et al. Sex differences in blood pressure and potential implications for Cardiovascular Risk Management. Hypertension. 2023;80(2):316\u201324.","journal-title":"Hypertension"},{"issue":"6","key":"672_CR116","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/01.HYP.24.6.793","volume":"24","author":"P Verdecchia","year":"1994","unstructured":"Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24(6):793\u2013801.","journal-title":"Hypertension"},{"issue":"7","key":"672_CR117","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1161\/HYPERTENSIONAHA.122.20589","volume":"80","author":"S Omboni","year":"2023","unstructured":"Omboni S, Khan NA, Kunadian V, Olszanecka A, Schutte AE, Mihailidou AS. Sex differences in Ambulatory Blood Pressure Levels and subtypes in a large Italian Community Cohort. Hypertension. 2023;80(7):1417\u201326.","journal-title":"Hypertension"},{"key":"672_CR118","doi-asserted-by":"publisher","first-page":"i4098","DOI":"10.1136\/bmj.i4098","volume":"354","author":"SL Stevens","year":"2016","unstructured":"Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;354:i4098.","journal-title":"BMJ"},{"issue":"9921","key":"672_CR119","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","volume":"383","author":"SS Mahmood","year":"2014","unstructured":"Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999\u20131008.","journal-title":"Lancet"},{"issue":"2","key":"672_CR120","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1385\/ENDO:28:2:199","volume":"28","author":"SM McBride","year":"2005","unstructured":"McBride SM, Flynn FW, Ren J. Cardiovascular alteration and treatment of hypertension: do men and women differ? Endocrine. 2005;28(2):199\u2013207.","journal-title":"Endocrine"},{"issue":"4","key":"672_CR121","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/00033197211036220","volume":"73","author":"S Chang","year":"2022","unstructured":"Chang S, Dai Y, Song X, Li C, Lu H, Huang Z, et al. Characteristics, management, and prognosis of spontaneous coronary intramural hematoma. Angiology. 2022;73(4):374\u20139.","journal-title":"Angiology"},{"issue":"1\u20135","key":"672_CR122","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0960-0760(02)00271-6","volume":"83","author":"C Behl","year":"2002","unstructured":"Behl C. Estrogen can protect neurons: modes of action. J Steroid Biochem Mol Biol. 2002;83(1\u20135):195\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"672_CR123","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13293-023-00518-7","volume":"14","author":"OJ Gannon","year":"2023","unstructured":"Gannon OJ, Naik JS, Riccio D, Mansour FM, Abi-Ghanem C, Salinero AE, et al. Menopause causes metabolic and cognitive impairments in a chronic cerebral hypoperfusion model of vascular contributions to cognitive impairment and dementia. Biol Sex Differ. 2023;14(1):34.","journal-title":"Biol Sex Differ"},{"issue":"1","key":"672_CR124","first-page":"69","volume":"158","author":"M Sarvari","year":"2017","unstructured":"Sarvari M, Kallo I, Hrabovszky E, Solymosi N, Liposits Z. Ovariectomy alters Gene expression of the hippocampal formation in Middle-aged rats. Endocrinology. 2017;158(1):69\u201383.","journal-title":"Endocrinology"},{"issue":"6","key":"672_CR125","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/HJH.0000000000002381","volume":"38","author":"K Tsioufis","year":"2020","unstructured":"Tsioufis K, Kreutz R, Sykara G, van Vugt J, Hassan T. Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature. J Hypertens. 2020;38(6):1016\u201328.","journal-title":"J Hypertens"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-024-00672-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-024-00672-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-024-00672-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T11:22:46Z","timestamp":1724066566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-024-00672-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["672"],"URL":"https:\/\/doi.org\/10.1007\/s11897-024-00672-y","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"6 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent Statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}